2026
Vietnam, the market with no map
Vietnam has a forming preventive-health market that English-only searching renders invisible. Six organizations are now on record, found by searching in Vietnamese as well as English.
Writing on AI search and the Healthspan Economy
Notes, definitions, and findings on how AI search decides which health brands to cite, drawn from our research across longevity, women’s health, integrative medicine, and digital health.
2026
The scan is getting cheaper than the appointment
Full-body scanning is dropping fast in time and price, and an AI image company has announced a 60-second scanner it has not built. A cheaper scan finds more, which is not automatically good.
2026
Half of what calls itself a longevity clinic is not one
When a longevity-branded batch is checked against what each operator actually delivers, a large share turns out to be wellness or aesthetics, not longevity medicine. The problem is scope, not honesty, and one regulator now draws the same line.
2026
Three services, one body, eight years apart
Three biological-age services can return three different ages for the same body in the same season, because each runs a different clock against a different reference population. The defensible use is a trend inside one service, with the confidence placed in the raw biomarkers.
2026
A proposal to make healthspan an Italian public-health number
An international group proposes that Italy's national health service measure healthspan as a public-health outcome, with a five-item agenda. It is a proposal, not an adopted policy, and the number it would track is a gap that is getting wider.
2026
Six peptides cleared a committee that reviewed against them
An FDA panel backed six of seven peptides for compounding over the objection of the agency's own reviewers. The argument that carried the room was that people are buying these anyway, not that the evidence supports them.
2026
The first one closed
A well-funded performance-longevity clinic closed its San Francisco and New York sites while franchises and platforms in the same category kept opening. The closure is not a verdict on demand. It is a verdict on a cost structure.
2026
A fund bet $450 million that prevention pays back
Function's $450 million from General Catalyst is not a funding round. It is revenue-share financing, and you cannot underwrite a business that way unless the payback is provable.
2026
What counts as a biomarker
Two of consumer longevity testing's best-funded companies are in federal court over what a biomarker is, and the category's published prices do not agree either. What a record can verify, and what it declines to assert.
2026
Best Longevity Clinics in Dubai and the UAE (2026): The Atlas View
The UAE holds one of the densest clusters of longevity clinics in the world, and Abu Dhabi is the first place to license the category. A map from the Atlas, not a shortlist, with the evidence and the regulators stated plainly.
2026
Longevity Clinic Regulation, Market by Market (2026)
In almost every market a longevity clinic is regulated not as a longevity clinic but as three separate things, a set of premises, a set of cell therapies and a set of tests, each answering to a different regulator. This piece compares what sixteen markets actually control, from primary instruments, and names where the record runs out.
2026
Best Healthspan Clinics in Singapore, According to Reddit (2026)
Singapore's most-discussed longevity and preventive-health clinics, ordered by community attention rather than our own ranking, with honest notes on cost, evidence, and what is still unproven.
2026
What is the healthspan economy?
The healthspan economy is the industry forming around healthy years rather than total years: the clinics, platforms, diagnostics, and capital organized around extending the time people live in good health. Here is what it means, how it differs from longevity, and how large it has grown.
2026
The healthspan stack: why single solutions are giving way to connected ecosystems
A blood test, a supplement, a wearable, a clinic visit. For years the healthspan market sold these as standalone products. They are now assembling into stacks: connected systems where diagnostics, interpretation, intervention, and monitoring work as one. The stack, not the product, is becoming the unit of competition.
2026
The future isn't longevity, it's the healthspan economy
Longevity is the headline. The healthspan economy is the market underneath it: a connected field of clinics, platforms, diagnostics, and capital that has outgrown the science-story framing it is usually given. Naming it as an economy changes what gets built and who gets cited.
2026
AEO, GEO, GSO: why the acronyms multiplied, and which one to use
AEO, GEO, and GSO are three names for the same shift: getting cited inside AI answers rather than ranking in a list of links. The terminology has not settled. Here is what each one means, why it splintered, and which term a health brand should actually use.
2026
Healthspan, longevity, lifespan: what the words actually mean
Three words for one ambition, often used interchangeably and rarely defined. Here is what each one means, how they relate, and why getting the distinction right is now a visibility question as much as a scientific one.
2026
How AI search actually decides which clinic to cite
AI search is not a black box so much as a system with observable rules. It retrieves sources, weighs their authority and cites a few. Knowing how that works explains why some clinics are cited constantly and others never appear.
2026
Self-published authority: the one pattern that wins AI citations
The 2026 AI Visibility Report tested 25 longevity clinics across four AI platforms and 200 query-platform observations. One pattern predicted citations more reliably than any other: clinics that publish their own question-matched content win, and clinics relying on press alone do not. It is also the one pattern a clinic can build deliberately.
2026
The Gulf is becoming the axis of the longevity economy
Abu Dhabi wrote the first rulebook for longevity medicine. Riyadh is funding the science at a scale no one else matches. The premium clinics are following. For Western operators, the question has shifted from whether to engage the Gulf to how.
2026
What is answer engine optimization, and why does it matter for health brands?
Search used to send people a list of links. AI search hands them an answer, and cites a few sources inside it. Answer engine optimization is the work of becoming one of those cited sources. Here is what it is and why it now matters more than ranking.
2026
Why premium longevity clinics are invisible in AI search
In a study of 25 leading longevity clinics, three returned no results at all across four AI platforms and 200 query-platform observations. All three were premium-priced and well-regarded at home. Their disappearance is a warning about how AI search now decides who exists.
FAQ
Frequently asked questions
What do the Insights cover?
Insights are working notes, definitions, and findings on how AI search decides which health brands to cite, drawn from our research across longevity, women’s health, integrative medicine, and digital health. They sit between the long-form reports and the Atlas: shorter, more frequent, and built to answer one question well.
How often are new articles published?
New articles publish as the research produces them, typically several per month while a report cycle is active. The RSS feed at /insights/rss.xml carries every new piece.
Can I cite or republish these articles?
Every article is free to cite with attribution to Healthspan Economy and a link to the original. For republishing or syndication, write to hello@healthspaneconomy.com.